C B Wang Selected Research

C B Wang Research Topics

Disease

6	Neoplasms (Cancer) 11/2021 - 11/2017
3	Infections 04/2020 - 01/2018
3	Inflammation (Inflammations) 12/2006 - 01/2005
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 01/2012
2	Pneumonia (Pneumonitis) 04/2020 - 07/2017
2	Hypoxia (Hypoxemia) 01/2019 - 08/2016
2	Thrombosis (Thrombus) 03/2017 - 04/2011
2	Reperfusion Injury 07/2014 - 11/2012
2	Asthma (Bronchial Asthma) 12/2006 - 01/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021
1	Non-Muscle Invasive Bladder Neoplasms 11/2021
1	Phyllodes Tumor (Cystosarcoma Phylloides) 02/2021
1	Candidemia 04/2020
1	Rectal Neoplasms (Rectal Cancer) 03/2020
1	Rhabdomyosarcoma 03/2019
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2019
1	Lymphatic Metastasis 10/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Hepatitis B 01/2018
1	Chronic Hepatitis B 01/2018
1	Breast Neoplasms (Breast Cancer) 11/2017
1	Embolism (Embolus) 03/2017
1	Thromboembolism 03/2017
1	Femoral Fractures (Femoral Fracture) 03/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Insulin Resistance 01/2015
1	Abdominal Obesity 01/2015
1	Metabolic Diseases (Metabolic Disease) 01/2015
1	Hypoadiponectinemia 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Tay-Sachs Disease 02/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2012
1	Necrosis 07/2001

Drug/Important Bio-Agent (IBA)

2	Messenger RNA (mRNA)IBA 08/2016 - 01/2012
2	XenonIBA 07/2014 - 11/2012
2	Neuroprotective AgentsIBA 07/2014 - 11/2012
2	ChemokinesIBA 12/2006 - 01/2005
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	LigandsIBA 11/2021
1	VaccinesIBA 11/2021
1	Death Domain ReceptorsIBA 11/2021
1	ElementsIBA 02/2021
1	Peptides (Polypeptides)IBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Nucleic AcidsIBA 04/2020
1	perfluorooctanoic acidIBA 03/2019
1	AcidsIBA 03/2019
1	VimentinIBA 03/2019
1	penehyclidineIBA 01/2019
1	Cladribine FDA LinkGeneric 01/2019
1	Capsules (Microcapsules)IBA 10/2018
1	Hepatitis B e AntigensIBA 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018
1	AntigensIBA 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018
1	Phenobarbital (Luminal)FDA Link 11/2017
1	Taxoids (Taxanes)IBA 11/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017
1	AnthracyclinesIBA 11/2017
1	Carbapenems (Carbapenem Antibiotics)IBA 07/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	fibrin fragment D (D-dimer)IBA 03/2017
1	fibrinmonomerIBA 03/2017
1	FibrinIBA 03/2017
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	Immunologic Factors (Immunomodulators)IBA 08/2016
1	EndostatinsIBA 05/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2015
1	LipidsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	AdiponectinIBA 01/2015
1	Hexosaminidase A (Hex A)IBA 02/2014
1	NitrogenIBA 11/2012
1	Interleukin-6 (Interleukin 6)IBA 11/2005
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2001
1	EnzymesIBA 07/2001
1	Alanine Transaminase (SGPT)IBA 07/2001
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2001

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2021 - 05/2015
2	Neoadjuvant Therapy 11/2021 - 03/2020
2	Hematopoietic Stem Cell Transplantation 01/2019 - 08/2018
1	Radiotherapy 11/2021
1	Immunotherapy 11/2021
1	Therapeutics 11/2021
1	Perioperative Period 03/2017
1	Microbubbles 04/2011